Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors

Atherosclerosis

Volumn 162, Issue 2, 2002, Pages 433-438

  Seminari, E ^a,b   Pan, A ^b   Voltini, G ^b   Carnevale, G ^b   Maserati, R ^a   Minoli, L ^a   Meneghetti, G ^a   Tinelli, C ^a   Testa, S ^c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b Istituti Ospitalieri ^*  (Italy)

^c Istituti Ospitalieri   (Italy)

Author keywords

Antiretroviral therapy; Cardiovascular risk; HIV infection; Intima media thickness; Protease inhibitor

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CELL COUNT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ECHOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTIMA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL, HDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; PROTEASE INHIBITORS; TRIGLYCERIDES; TUNICA INTIMA; TUNICA MEDIA;

EID: 0036234629     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00736-5     Document Type: Article

References (28)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: A cohort study
3. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected men
4. Vascular complications associated with use of HIV protease inhibitors
5. Vascular complications associated with use of HIV protease inhibitors
6. Vascular complications associated with use of HIV protease inhibitors
7. Severe premature coronary artery disease with protease inhibitors
8. Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment?
9. Premature atherosclerosis in HIV-infected individuals - Focus on protease inhibitor therapy
10. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors
11. Diagnosis and determinants of subclinical arterial disease in HIV1-infected patients on HAART
12. A pilot study of carotid intima media thickness in HIV-infected women treated with protease inhibitors
13. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging
14. Plasminogen activator inhibitor-1 and carotid intima-media thickening in patients with newly detected primary hypertension
15. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
16. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency syndrome
17. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
18. HIV Protease inhibitor-related lipodystrophy syndrome
19. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
20. Blood pressure as a risk factor for cardiovascular disease: The Framingham Study - 30 years of follow-up
21. Is relationship between serum cholesterol and risk of premature coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
22. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: Comparison with the 'minimal model'. Insulin Resistance Atherosclerosis Study (IRAS) Investigators
23. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography
24. Carotid-artery intima media thickness as a risk factor for myocardial infarction and stroke in older adults
25. Carotid wall thickness is predictive of incident clinical stroke
26. Myocardial infarction incidence in clinical trials of four protease inhibitors
27. Do protease inhibitors increase the risk for coronary heart disease among HIV-positive patients? Additional follow up?
28. Impact of treatment with protease inhibitor (PI) on myocardial infarction (MI) occurrence in HIV-infected men